-
Researchers artificially cultivated luminescent fungus
Time of Update: 2022-01-01
China News Service, Kunming, November 23 (Reporter Hu Yuanhang) The reporter learned from the Xishuangbanna Tropical Botanical Garden of the Chinese Academy of Sciences on the 23rd that the scientific research team of the garden has successfully isolated and obtained the fluorescent umbilical mushroom.
-
Comprehensive news: Many countries report a new variant of new coronavirus or more resistant to vaccines
Time of Update: 2022-01-01
The Ministry of Health of Botswana reported on the 25th that the country has reported 4 cases of infection with this mutant strain .
-
New knowledge about the most important biochemical reaction on earth: a step for plants to absorb carbon dioxide
Time of Update: 2022-01-01
In a new study published in the scientific journal Proceedings of the National Academy of Sciences, researchers from the Department of Plant and Environmental Sciences at the University of Copenhagen have just discovered that a group of proteins called CURT1 in plant leaf cells play a role in photosynthesis.
-
Billions of people are infected and carry it for life. Studies have found that it hijacks normal protein to spread!
Time of Update: 2022-01-01
In general, dynein carries HSV-1 from the end of the axon to the center of the neuron, and kinesin carries the virus to the nucleus .
-
First-line cervical cancer: Hengrui PD-L1/TGFβ bifunctional fusion protein starts phase III clinical trials
Time of Update: 2022-01-01
On November 23, the Insight database showed that Hengrui Medicine launched a phase III clinical trial to explore the combination of PD-L1/TGFβ bifunctional fusion protein SHR-1701 combined with chemotherapy and bevacizumab-like drug BP102 as the first-line treatment for cervical cancer .
-
Does the detection of antibody levels know the protective efficacy of the new crown vaccine?
Time of Update: 2022-01-01
. Recently, the top academic journal "Science" published the results of a clinical trial, providing important data on the relationship between the level of antibodies induced by the new crown vaccine and the protection against infection .
-
The cover of "Cell" is heavy. We can think of RNA too simple...
Time of Update: 2022-01-01
A cover paper recently published in the top academic journal "Cell" reveals another important function of RNA-dividing different spaces in the nucleus, affecting the contact between DNA, the assembly of heterochromatin, and genes.
-
Novartis DARPin protein therapy ensovibep failed to treat hospitalized COVID-19 patients!
Time of Update: 2022-01-01
In the COVID-19 study sponsored by the National Institutes of Health (NIH), the new multispecific antiviral DARPin protein therapy ensovibep, which is a collaboration between Molecular Partners and Novartis, failed to pass the test, making it hopeful that it would remain in the treatment of non-hospital patients.
-
Causes of biodiversity loss
Time of Update: 2022-01-01
Sara Redlich of the Julius-Maximilians-Universit?t Würzburg Biological Center (JMU) in Bavaria, Germany, accepted this challenge in the Landcliffe project, which investigated the effects of climate change and land use on species diversity The impact of sex .
-
Reindeer Medical announces the completion of the first patient enrollment and apheresis in the CT120 Phase I/II registered clinical study
Time of Update: 2022-01-01
Nanjing, Shanghai and San Francisco, November 10, 2021/PRNewswire/ - Reindeer Medical today announced its self-developed fully human dual target CD19/CD22 chimeric antigen receptor autologous T cell injection (CT120) I / Phase II registration clinical trial, the first patient enrollment and apheresis have been completed, and it is planned to be used for the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL) .
-
Pfizer deploys innovative protein degradation technology to selectively target tumor tissues
Time of Update: 2022-01-01
On November 29, 2021, Ranok Therapeutics announced an agreement with Pfizer to use the company’s proprietary molecular chaperone-mediated targeted protein degradation (CHAMP) technology platform to target an undisclosed Of cancer targets to develop innovative therapies .
-
Biological pesticides can be used to degrade aflatoxins in crops
Time of Update: 2022-01-01
Maxwell said: "Our research provides detailed evidence that toxin-producing biological control Aspergillus strains can not only prevent aflatoxin contamination, but also degrade aflatoxin that is already present in crops .
-
This predictive system allows complicated eye injury surgery to bid farewell to "blindness"
Time of Update: 2022-01-01
Recently, Professor Yan Hua, head of the Ophthalmology Group of the Ophthalmology Branch of the Chinese Medical Association of Tianjin Medical University, teamed up with multidisciplinary experts to establish the world’s first VisionGo based on more than 20 years of clinical and basic research on the treatment of complex ocular trauma.
-
Global ocean imbalance: humans seem to have broken the laws of nature
Time of Update: 2022-01-01
Surprisingly, all life forms in the ocean, from small krill to large tuna, seem to follow a simple mathematical law, which relates the number of organisms to their body size .
-
Virtual imaging technology: "Digital New Medicine" helps precision medicine
Time of Update: 2022-01-01
Xiong Yan said: "The use of MR technology in surgery can fuse and superimpose virtual images with real anatomical structures, which is equivalent to installing a'perspective eye' for the doctor, so as to perform more precise surgical treatment for the patient .
-
CRISPR gene editing improved and innovative CAR-T therapy was recognized by the FDA as an advanced therapy for regenerative medicine
Time of Update: 2022-01-01
The detailed relief information for each different dose is shown in the figure below:▲Efficacy data of phase 1 clinical trial of CTX110 (picture source: reference [2])Reference materials:[1] CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX110™ for the Treatment of Relapsed or Refractory CD19+ B-cell malignancies.
-
Protollin Alzheimer's Disease Preventive Vaccine for Nasal Use Starts Trial
Time of Update: 2022-01-01
At the end of July this year, Tianjing Biotechnology announced that Protollin, a new drug under development for the treatment of Alzheimer's disease, was approved by the FDA to initiate a phase 1 clinical trial .
-
Innovative therapy targeting Nobel Prize signaling pathway in renal cell carcinoma, disease control rate reached 98%
Time of Update: 2022-01-01
(MSD) for the treatment of renal cell carcinoma patients related to von Hippel-Lindau (VHL) disease were published in the New England Journal of Medicine .
-
Research reveals the role of bacteria in the global carbon cycle
Time of Update: 2022-01-01
, "Multi-Substrate DNA stable isotope survey reveals the structure of guild bacteria regulating soil carbon cycle," published on November 19 in the "Proceedings of the National Academy of Sciences" .
Barkley said: "This method allows us to identify isotope-labeled DNA and find out which microorganisms eat each different type of carbon .
-
AI predicts the animals most likely to spread the new coronavirus
Time of Update: 2022-01-01
However, the ACE2 protein of different species is different, so knowing the degree of binding of its ACE2 protein to the coronavirus spike protein can help predict which animals are most likely to infect and spread the new coronavirus .
